("Agronomics" or the "Company")
Net Asset Value calculation as at
The share price of
Agronomics has a healthy balance sheet entering into 2024 and intends to preserve the majority of its capital for follow-on investments into its existing portfolio companies to assist with the achievement of major milestones such as regulatory approvals, product launches, or building out their commercial facilities. The Company continues to monitor and review new and emerging technologies within the field of cellular agriculture and will also look to expand the portfolio for further diversification should the opportunity arise.
Financing
During the period, 2,210 new ordinary shares were issued following the exercise of warrants. Gross proceeds of
The Board approved a share buyback programme for an aggregate amount of up to
Investment review
During the 3-month period, the Company had two positive revaluations and saw the portfolio companies receive government support and form new strategic partnerships:
·
·
·
·
|
|
Unaudited to £ |
Current Assets |
|
|
|
Investments |
145,879,692 |
|
Uninvested cash and deposits |
22,007,344 |
|
Trade and other receivables |
142,258 |
Current Liabilities |
|
|
|
Trade and other creditors |
(203,046) |
Net Assets |
|
167,826,248 |
Capital and Reserves |
|
|
|
Share capital |
993 |
|
Share premium |
134,482,024 |
|
Share reserve |
1,686,336 |
|
Retained earnings |
31,656,895 |
Net assets |
|
167,826,248 |
Shares in Issue |
|
993,154,244 |
Net Asset Value per share |
|
|
The quoted investments within the portfolio are valued under IFRS at bid price.
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014, as it forms part of
ENDS
For further information please contact:
|
|
|
|
|
SEC Newgate |
The Company |
Nomad |
Joint Broker |
Joint Broker |
Joint Broker |
Public Relations |
|
|
|
|
|
|
+44 (0) 1624 639396 |
+44 (0) 207 628 3396 |
+44 (0) 207 523 8000 |
+44 (0) 207 397 8900 |
+44 (0) 207 469 0936 |